Clinical trial Recruiting at 1 site Interventional Ages 6 to 14

Outcomes for children with obesity in the Get Up & Go healthy lifestyle program

Official title: Comparison Study to Evaluate the Outcomes Among Children Participating in a Community Healthy Lifestyle Program

Run by University of Texas Southwestern Medical Center · NCT07342855 · Data updated 2026-11-12

This project will try whether the Get Up & Go family healthy lifestyle program helps children ages 6–14 with BMI at or above the 85th percentile improve health and activity measures compared with a waitlisted group.

More Overweight , Obesity trials

Quick facts

Study typeInterventional
Ages6 Years to 14 Years
SexAll
Enrollment160 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT07342855 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6–14 with a reported BMI at or above the 85th percentile who can participate in elementary-school-level physical activity and whose parent/guardian speaks English or Spanish.

Probably not a fit

Children with BMI below the 85th percentile or those unable to participate in the required physical activity or with lower cognitive functioning are not likely to benefit from this program enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Referred families who enroll in the Get Up & Go program are randomized in an unblinded design to start the program immediately or join a waitlist control, with additional measurements taken to track changes over time. Children eligible are 6–14 years old with reported BMI ≥85th percentile and must be able to participate in activity similar to an elementary school PE class and have cognitive function at or above that of a 6-year-old. Outcome measures include family nutrition and physical activity questionnaires (FNPA, BAQ), endurance tests, and percent BMIp95 among others, collected by study staff at specified timepoints. Consent/assent and optional parent measurements are offered in English or Spanish, and enrollment occurs through the Get Up & Go referral process at Children's Health in Dallas.

Why it matters

Potential benefit: If successful, the program could help participating children improve physical activity, nutrition habits, and weight-related measures.

How similar studies have gone: Family-based healthy lifestyle programs like this have previously produced modest improvements in BMI and health behaviors, so this approach builds on existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI by report of ≥ 85th percentile
* The child must be able to participate in physical activity comparable to an elementary school PE class and must be able to function cognitively at or above the level of a 6 year old

Exclusion Criteria:

* BMI by report of below the 85th percentile
* Inability to participate in physical activity comparable to an elementary school PE class and must be able to function cognitively at or above the level of a 6 year old

Parent will be invited but not required to be weighed and measured.

Where it's running

  • University of Texas Southwestern, Children's Health
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

    This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

    Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

  • UBT37034 Injection safety study in adults with overweight or obesity

    This study tests different doses of UBT37034 injections to see if they are safe and tolerable in adults who are overweight or have obesity.

    Recruiting Phase 1 The United Bio-Technology (Hengqin) Co., Ltd. · Changsha, Hunan · NCT07873645

  • Two-Week Stair-Climbing “Exercise Snacks” to Test Metabolic Health

    In adults with overweight or obesity who don’t exercise regularly, a two-week program of short stair climbs throughout the day will be tested to see if it improves metabolic health and fitness.

    Recruiting St. Louis University · St Louis, Missouri · NCT07849439

  • Tegileridine for pain after bariatric surgery

    This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.

    Recruiting Phase 3 The First Hospital of Jilin University · Changchun, Jilin · NCT07844512

  • Weight-loss maintenance with ALV-100 after prior weight loss

    This study tests whether ALV-100 helps adults who already lost weight with incretin therapies keep the weight off, compared with placebo.

    Recruiting at 20 sites Phase 2 Alveus Therapeutics, Inc. · Birmingham, Alabama and 19 other locations · NCT07837973

  • Nudge-Based Exercise for Obese Adolescents

    A nudge-based exercise program is being tested to see if it helps overweight teens start and keep up physical activity and improve BMI.

    Recruiting Nanjing Children's Hospital · Nanjing, Jiangsu · NCT07824453

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.